Global Orally Disintegrating Tablet Competitive Landscape Professional Research Report 2024

Global Orally Disintegrating Tablet Competitive Landscape Professional Research Report 2024

Research Summary

Orally disintegrating tablets (ODTs) are pharmaceutical dosage forms designed to disintegrate or dissolve rapidly in the mouth without the need for water or chewing. These tablets offer a convenient and user-friendly method of administering medications, particularly for individuals who have difficulty swallowing traditional tablets or capsules. ODTs are commonly used for a wide range of medications, including pain relievers, antihistamines, and medications for conditions like allergies or epilepsy. The tablets disintegrate quickly in saliva, allowing for rapid absorption of the active ingredient through the oral mucosa, which can lead to faster onset of action. ODTs have found wide acceptance in both pediatric and geriatric patient populations, as well as among individuals with compliance issues, making them a valuable option in pharmaceutical formulations.

According to DIResearch's in-depth investigation and research, the global Orally Disintegrating Tablet market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Orally Disintegrating Tablet include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Otsuka, Conquer etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Orally Disintegrating Tablet. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Orally Disintegrating Tablet market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Orally Disintegrating Tablet market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Orally Disintegrating Tablet industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Orally Disintegrating Tablet Include:

Teva

Merck

Mylan

Pfizer

Johnson and Johnson

GSK

Bristol-Myers Squibb

Eli Lilly and Company

AstraZeneca

Otsuka

Conquer

Orally Disintegrating Tablet Product Segment Include:

Anti-Psychotics Drug

Anti-Epileptics Drug

Others

Orally Disintegrating Tablet Product Application Include:

CNS Diseases

Gastrointestinal Diseases

CVS Diseases

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Orally Disintegrating Tablet Industry PESTEL Analysis

Chapter 3: Global Orally Disintegrating Tablet Industry Porter’s Five Forces Analysis

Chapter 4: Global Orally Disintegrating Tablet Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Orally Disintegrating Tablet Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Orally Disintegrating Tablet Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Orally Disintegrating Tablet Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Orally Disintegrating Tablet Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Orally Disintegrating Tablet Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Orally Disintegrating Tablet Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Orally Disintegrating Tablet Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Orally Disintegrating Tablet Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources